UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

Date of Report (Date of earliest event reported): March 24, 2014

 

AmerisourceBergen Corporation

(Exact name of Registrant as specified in its charter)

 

Delaware

 

1-16671

 

23-3079390

(State or Other

 

Commission File Number

 

(I.R.S. Employer

Jurisdiction of

 

 

 

Identification

Incorporation or

 

 

 

Number)

Organization)

 

 

 

 

 

 

1300 Morris Drive

 

 

Chesterbrook, PA

 

19087

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code:  (610) 727-7000

 

N/A

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


 

Item 8.01.                                        Other Events.

 

On March 24, 2014, AmerisourceBergen Corporation (the “Company”) issued a news release announcing that it had reached a definitive agreement to acquire a minority stake in Profarma Distribuidora de Produtos Farmacêuticos S.A. (“Profarma”), a leading pharmaceutical wholesaler in Brazil.  In addition, the Company and Profarma will establish a joint venture for specialty distribution and services.  The Company expects to invest a total of approximately $100 million, and the transaction is expected to close in the June quarter of fiscal year 2014.  The Company does not expect the transaction to have a meaningful impact to its adjusted earnings per share from continuing operations for fiscal year 2014.

 

The news release issued on March 24, 2014 is filed as Exhibit 99.1 to this report and is incorporated herein by reference.

 

Item 9.01.                                        Financial Statements and Exhibits.

 

(d) Exhibit

 

The following exhibit is filed as part of this report:

 

99.1 News Release, dated March 24, 2014, of AmerisourceBergen Corporation.

 

2


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

AMERISOURCEBERGEN CORPORATION

 

 

Date: March 25, 2014

By:

/s/ Tim G. Guttman

 

Name:

Tim G. Guttman

 

Title:

Senior Vice President and Chief Financial Officer

 

3